The Effects of the Nurse Navigation Program in Promoting Colorectal Cancer Screening Behaviors: a Randomized Controlled Trial

  • Elif TemucinEmail author
  • Nursen O. Nahcivan


Although screening programs are known and recommended for the early detection of colorectal cancer (CRC), the screening rates for the fecal occult blood test (FOBT) and colonoscopy are very low among adult individuals. Navigation programs, also known as individualized counseling, have recently begun to be used for increasing screening rates. The purpose of this study was to compare the efficacy of the Nurse Navigation Program versus usual care on CRC screening participation and movement in stage of adoption for CRC screening and to examine perceived benefits of and barriers to CRC screening. This study was designed in line with a pre- and posttest two-group methodology. A total of 110 participants (55 nurse-navigated and 55 non-navigated patients) were studied. Data were collected using the following three tools: a sociodemographic information form, the Harvard Colorectal Cancer Risk Assessment Tool, and Instruments to Measure Colorectal Cancer Screening Benefits and Barriers. Following the Nurse Navigation Program, the FOBT (82 and 84%, respectively) and colonoscopy completion rates (15 and 22%, respectively) were significantly higher in the nurse-navigated group than in the non-navigated group at 3 and 6 months follow-up. Following the program, the benefit perceptions of the nurse-navigated group about CRC screening were improved, and their barrier perceptions were reduced. The results showed that the Nurse Navigation Program had significant effects on CRC screening behavior and health-related beliefs concerning CRC screening. Further assessment of the Nurse Navigation Program in different groups should be performed to observe its effects.


Colorectal cancer Cancer screening Nurse navigation Transtheoretical model 



  1. 1.
    World Health Organization (WHO) 2012. GLOBOCAN 2012 estimated cancer incidence, mortality and prevelance worldwide in 2012. Accessed 28 June 2018
  2. 2.
    Public Health Agency of Turkey Ministry of Health, Department of Cancer. 2017. Turkey Cancer Statistics. .Accessed 28 June 2018
  3. 3.
    Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Garcia FA et al (2016) Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 315(23):2564–2575. CrossRefPubMedGoogle Scholar
  4. 4.
    Canadian Task Force on Preventive Health Care (2016) Recommendations on screening for colorectal cancer in primary care. Can Med Assoc J 188(5):340–348. CrossRefGoogle Scholar
  5. 5.
    von Karsa L, Patnick J, Segnan N, Atkin W, Halloran S et al (2013) European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 45(1):51–59. CrossRefGoogle Scholar
  6. 6.
    Atkin W, Cook C, Cuzick J, Edwards R (2002) Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 359(9314):1291CrossRefGoogle Scholar
  7. 7.
    Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM et al (2010) Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375(9726):1624–1633. CrossRefGoogle Scholar
  8. 8.
    Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M et al (2011) Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial SCORE. J Natl Cancer Inst 103(17):1310–1322. CrossRefGoogle Scholar
  9. 9.
    Brenner H, Stock C, ve Hoffmeister M. (2014) Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 348:2467. CrossRefGoogle Scholar
  10. 10.
    Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, AmarSS BTW et al (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348(9040):1472–1477CrossRefGoogle Scholar
  11. 11.
    UK Flexible Sigmoidoscopy Screening Trial Investigators (2002) Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 359(9314):1291–1300CrossRefGoogle Scholar
  12. 12.
    Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, ve Tsugane S. (2007) Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan. Cancer Detect Prev 31(1):3–11. CrossRefPubMedGoogle Scholar
  13. 13.
    Wilkins T, Gillies RA, Harbuck S, Garren J, Looney SW, Schade RR (2012) Racial disparities and barriers to colorectal cancer screening in rural areas. J Am Board Fam Med 25(3):308–317CrossRefGoogle Scholar
  14. 14.
    Gimeno Garcia AZ, Hernandez Alvarez Buylla N, Nicolas-Perez D, Quintero E (2014) Public awareness of colorectal cancer screening: knowledge, attitudes, and interventions for increasing screening uptake. ISRN Oncol. CrossRefGoogle Scholar
  15. 15.
    Gulten G, Memnun S, Ayse K, Aygul A, ve Gulcin A. (2012) Breast, cervical, and colorectal cancer screening status of a group of Turkish women. Asian Pac J Cancer Prev 13(9):4273–4279. CrossRefPubMedGoogle Scholar
  16. 16.
    Koo JH, Arasaratnam MM, Liu K, Redmond DM, Connor SJ, Sung JJ, ve Leong RW. (2010) Knowledge, perception and practices of colorectal cancer screening in an ethnically diverse population. Cancer Epidemiol 34(5):604–610. CrossRefPubMedGoogle Scholar
  17. 17.
    Percac-Lima S, Grant RW, Green AR, Ashburner JM, Gamba G, Oo S, Richter JM, Atlas SJ (2009) A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med 24(2):211–217. CrossRefPubMedGoogle Scholar
  18. 18.
    Powe BD, Ntekop E, Barron M (2004) An intervention study to increase colorectal cancer knowledge and screening among community elders. Public Health Nurs 21(5):435–442. CrossRefPubMedGoogle Scholar
  19. 19.
    Sabatino SA, Lawrence B, Elder R, Mercer SL, Wilson KM, DeVinney et al (2012) Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med 43(1):97–118. CrossRefPubMedGoogle Scholar
  20. 20.
    Wang HL, Christy MSM, Skinner CS, Champion VL, Springston JK, Perkins SM et al (2014) Predictors of stage of adoption for colorectal cancer screening among African American primary care patients. Cancer Nurs 37(4):241–251. CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    American Cancer Society (ACS) (2017) Colorectal cancer facts and figures 2017-2019. Erişim Tarihi: 28.06.2017. . Accessed 28 June 2017
  22. 22.
    Organisation for Co-operation and Development (OECD) (2014) Health at a glance: Europe. Erişim Tarihi: 28.06.2017 Accessed 28 June 2017
  23. 23.
    Baron RC, Rimer BK, Breslow RA, Coates RJ, Kerner J, Melillo S, Habarta N, Kalra GP, Chattopadhyay S, Wilson KM, Lee NC, Mullen PD, Coughlin SS, Briss PA (2008) Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening: a systematic review. Am J Prev Med 35(1):S34–S55. CrossRefPubMedGoogle Scholar
  24. 24.
    Domingo JLB, Braun KL (2017) Characteristics of effective colorectal cancer screening navigation programs in federally qualified health centers: a systematic review. J Health Care Poor Underserved 28(1):108–126. CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Escoffery C, Rodgers KC, Kegler MC, Haardörfer R, Howard DH, Liang S, Pinsker E, Roland KB, Allen JD, Ory MG, Bastani R, Fernandez ME, Risendal BC, Byrd TL, Coronado GD (2014) A systematic review of special events to promote breast, cervical and colorectal cancer screening in the United States. BMC Public Health 14(1):274CrossRefGoogle Scholar
  26. 26.
    Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R (2010) Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med 152(10):668–676CrossRefGoogle Scholar
  27. 27.
    Rawl SM, Menon U, Burness A, Breslau ES (2012) Interventions to promote colorectal cancer screening: an integrative review. Nurs Outlook 60(4):172–181. CrossRefGoogle Scholar
  28. 28.
    Wells KJ, Battaglia TA, Dudley DJ, Garcia R, Greene A, Calhoun E, Patient Navigation Research Program (2008) Patient navigation: state of the art or is it science? Cancer 113(8):1999–2010. CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Beydoun HA, Beydoun MA (2008) Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control 19(4):339–359. CrossRefPubMedGoogle Scholar
  30. 30.
    Chapple A, Ziebland S, Hewitson P, McPherson A (2008) What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): a qualitative study. Soc Sci Med 66(12):2425–2435. CrossRefPubMedGoogle Scholar
  31. 31.
    Gimeno Garcia AZ (2012) Factors influencing colorectal cancer screening participation. Gastroenterol Res Pract. Article ID:483417. CrossRefGoogle Scholar
  32. 32.
    Natale-Pereira A, Marks J, Vega M, Mouzon D, Hudson SV, Salas-Lopez D (2008) Barriers and facilitators for colorectal cancer screening practices in the Latino community: perspectives from community leaders. Cancer Control 15(2):157–165CrossRefGoogle Scholar
  33. 33.
    Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML (2005) Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care 43:939–944CrossRefGoogle Scholar
  34. 34.
    Goodman MJ, Ogdie A, Kanamori MJ, Canar J, O Malley AS. (2006) Barriers and facilitators of colorectal cancer screening among Mid-Atlantic Latinos: focus group findings. Ethn Dis 16(1):255–261PubMedGoogle Scholar
  35. 35.
    James AS, Campbell MK, Hudson MA (2002) Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: how does perception relate to screening behavior? Cancer Epidemiol Biomark Prev 11(6):529–534Google Scholar
  36. 36.
    Janz NK, Wren PA, Schottenfeld D, Guire KE (2003) Colorectal cancer screening attitudes and behavior: a population-based study. Prev Med 37(6):627–634. CrossRefPubMedGoogle Scholar
  37. 37.
    Manne S, Markowitz A, Winawer S, Meropol NJ, Haller D, Rakowski W et al (2002) Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol 21(1):3–15CrossRefGoogle Scholar
  38. 38.
    Brenner AT, Getrich CM, Pignone M, Rhyne RL, Hoffman RM, McWilliams A, de Hernandez B, Weaver MA, Tapp H, Harbi K, Reuland D (2014) Comparing the effect of a decision aid plus patient navigation with usual care on colorectal cancer screening completion in vulnerable populations: study protocol for a randomized controlled trial. Trials 15:275CrossRefGoogle Scholar
  39. 39.
    Giunti A (2013) Nurse navigation and the transition to cancer survivorship: a review of determinants essential to program success. Int J Health Sci 3(2):27–31 Google Scholar
  40. 40.
    Ritvo PG, Myers RE, Paszat LF, Tinmouth JM, McColeman J, Mitchell B, Serenity M, Rabeneck L (2015) Personal navigation increases colorectal cancer screening uptake. Cancer Epidemiol Biomark Prev 24(3):506–511CrossRefGoogle Scholar
  41. 41.
    DeGroff A, Coa K, Morrissey KG, Rohan E, Slotman B (2013) Key considerations in designing a patient navigation program for colorectal cancer screening. Health Promot Pract 15(4):483–495. CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Hendren S, Fiscella K (2014) Patient navigation improves the care experience for patients with newly diagnosed cancer. J Clin Oncol 32(1):3–4CrossRefGoogle Scholar
  43. 43.
    Hopkins J, Mumber MP (2009) Patient navigation through the cancer care continuum: an overview. J Oncol Pract 5(4):150–152CrossRefGoogle Scholar
  44. 44.
    Nguyen TUN, ve Kagawa-Singer M (2008) Overcoming barriers to cancer care through health navigation programs. Semin Oncol Nurs 24(4):270–278. CrossRefPubMedGoogle Scholar
  45. 45.
    Eschiti V, Burhansstipanov L, Watanabe-Galloway S (2012) Native cancer navigation: the state of the science. Clin J Oncol Nurs 16(1):73–82, 89. CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Escoffery C, Fernandez ME, Vernon SW, Liang S, Maxwell AE, Allen JD, Dwyer A, Hannon PA, Kohn M, DeGroff A (2015) Patient navigation in a colorectal cancer screening program. J Public Health Manag Pract 21(5):433–440. CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Muliira JK, ve D’souza MS. (2016) Effectiveness of patient navigator interventions on uptake of colorectal cancer screening in primary care settings. Jpn J Nurs Sci 13(2):205–219. CrossRefPubMedGoogle Scholar
  48. 48.
    Ramachandran A, Snyder FR, Katz ML, Darnell JS, Dudley DJ, Patierno SR et al (2015) Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: data from the Patient Navigation Research Program. Cancer 121(22):4016–4024. CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Prochaska JO, Wright JA, Velicer WF (2008) Evaluating theories of health behavior change: a hierarchy of criteria applied to the Transtheoretical Model. Appl Psychol 57(4):561–588. CrossRefGoogle Scholar
  50. 50.
    Duncan A, Wilson C, Cole SR, Mikocka-Walus A, Turnbull D, ve Young GP. (2009) Demographic associations with stage of readiness to screen for colorectal cancer. Health Promot J Austr 20(1):7–12CrossRefGoogle Scholar
  51. 51.
    Prochaska JO, Redding CA, Evers KE (2008) The Transtheoretical Model and stages of change. In: Rımer KGBK, Vıswanath K (eds) Health behavior and health education theory, research and practice. Jossey-Bass Publications, San Francisco, pp 97–117Google Scholar
  52. 52.
    Rawl SM, Menon U, Champion V, May F, Loehrer P, Hunter C et al (2005) Do benefits and barriers differ by stage of adoption for colorectal cancer screening? Health Educ Res 20(2):137–148. CrossRefPubMedGoogle Scholar
  53. 53.
    Dietrich AJ, Tobin JN, Cassells A, Robinson CM, Greene MA, Sox C et al (2006) Telephone care management to improve cancer screening among low-income women. Ann Intern Med 144(8):563–571. CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Lasser KE, Murillo J, Lisboa S, Casimir AN, Valley-Shah L, Emmons KM et al (2011) Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med 171(10):906–912CrossRefGoogle Scholar
  55. 55.
    Lasser KE, Murillo J, Medlin E, Lisboa S, Valley-Shah L, Fletcher RH et al (2009) A multilevel intervention to promote colorectal cancer screening among community health center patients: results of a pilot study. BMC Fam Pract 10(1):37. CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Atun R (2015) Transforming Turkey’s health system—lessons for universal coverage. N Engl J Med 373(14):1285–1289. CrossRefPubMedGoogle Scholar
  57. 57.
    Ocek ZA, Ciceklioglu M, Yucel U, Ozdemir R (2015) Erratum: family medicine model in Turkey: a qualitative assessment from the perspectives of primary care workers. BMC Fam Pract 16:74. CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Güngen C, Ertan T, Eker E, Yaşar R, Engin F (2002) Reliability and validity of the standardized Mini Mental State Examination in the diagnosis of mild dementia in Turkish population. Turk J Psychiatry 13(4):273–281Google Scholar
  59. 59.
    Lipkus IM, Lyna PR, ve Rimer BK. (2000) Colorectal cancer risk perceptions and screening intentions in a minority population. J Natl Med Assoc 92(10):492–500PubMedPubMedCentralGoogle Scholar
  60. 60.
    Menon U, Belue R, Skinner CS, Rothwell BE, Champion V (2007) Perceptions of colon cancer screening by stage of screening test adoption. Cancer Nurs 30(3):178–185. CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Trauth JM, Ling BS, Weissfeld JL, Schoen RE, ve Hayran M. (2003) Using the transtheoretical model to stage screening behavior for colorectal cancer. Health Educ Behav 30(3):322–336. CrossRefPubMedGoogle Scholar
  62. 62.
    Colditz G, Atwood K, Emmons K, Monson R, Willett W, Trichopoulos D, Hunter D (2000) Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Cancer Causes Control 11(6):477–488CrossRefGoogle Scholar
  63. 63.
    Kim DJ, Rockhill B, Colditz GA (2004) Validation of the Harvard Cancer Risk Index: a prediction tool for individual cancer risk. J Clin Epidemiol 57(4):332–340. CrossRefPubMedGoogle Scholar
  64. 64.
    Rawl S, Champion V, Menon U, Loehrer PJ Sr, Vance GH, Skinner CS (2001) Validation of scales to measure benefits of and barriers to colorectal cancer screening. J Psychosoc Oncol 19(3–4):47–63. CrossRefGoogle Scholar
  65. 65.
    Lachin JM (2016) Fallacies of last observation carried forward analyses. Clin Trials 13(2):161–168. CrossRefPubMedGoogle Scholar
  66. 66.
    Molnar FJ, Hutton B, Fergusson D (2008) Does analysis using “last observation carried forward” introduce bias in dementia research? Can Med Assoc J 179(8):751–753CrossRefGoogle Scholar
  67. 67.
    Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA (2007) Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health 10(5):415–430. CrossRefPubMedGoogle Scholar
  68. 68.
    Public Health Agency of Turkey Ministry of Health, Department of Cancer. National Standards for Colorectal Cancer Screening Program. Accessed 28 June 2018
  69. 69.
    Stracci F, Zorzi M, Grazzini G (2014) Colorectal cancer screening: tests, strategies, and perspectives. Front Public Health 2:210. CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Jandorf L, Gutierrez Y, Lopez J, Christie J, Itzkowitz SH (2005) Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic. J Urban Health 82(2):216–224. CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Myers RE, Hyslop T, Sifri R, Bittner-Fagan H, Katurakes NC, Cocroft J et al (2008) Tailored navigation in colorectal cancer screening. Med Care 46(9):S123–S131 ISSN: 0025-7079/08/4600-0123CrossRefGoogle Scholar
  72. 72.
    Horne HN, Phelan-Emrick DF, Pollack CE, Markakis D, Wenzel J, Ahmed S et al (2015) Effect of patient navigation on colorectal cancer screening in a community-based randomized controlled trial of urban African American adults. Cancer Causes Control 26(2):239–246. CrossRefPubMedGoogle Scholar
  73. 73.
    Green AR, Peters-Lewis A, Percac-Lima S, Betancourt JR, Richter JM, Janairo MP et al (2008) Barriers to screening colonoscopy for low-income Latino and white patients in an urban community health center. J Gen Intern Med 23(6):834–840CrossRefGoogle Scholar
  74. 74.
    Ojinnaka C, Vuong A, Helduser J, Nash P, Ory MG, McClellan DA, Bolin JN (2015) Determinants of variations in self-reported barriers to colonoscopy among uninsured patients in a primary care setting. J Community Health 40(2):260–270. CrossRefPubMedGoogle Scholar
  75. 75.
    Public Health Agency of Turkey Ministry of Health, Department of Cancer. Cancer screening. Accessed 20 June 2018
  76. 76.
    Lawsin C, DuHamel K, Weiss A, Rakowski W, Jandorf L (2007) Colorectal cancer screening among low-income African Americans in East Harlem: a theoretical approach to understanding barriers and promoters to screening. J Urban Health 84(1):32–44. CrossRefPubMedGoogle Scholar
  77. 77.
    Sanchez JI, Palacios R, Thompson B, Martinez V, O’Connell MA (2013) Assessing colorectal cancer screening behaviors and knowledge among at-risk Hispanics in Southern New Mexico. J Cancer Ther 4(6):15–25. CrossRefPubMedPubMedCentralGoogle Scholar
  78. 78.
    Gregory T, Cole SR, Wilson CJ, Flight IH, Zajac IT, Turnbull D et al (2013) Exploring the validity of the continuum of resistance model for discriminating early from late and non-uptake of colorectal cancer screening: implications for the design of invitation and reminder letters. Int J Behav Med 20(4):572–581. CrossRefPubMedGoogle Scholar
  79. 79.
    Ma GX, Shive S, Tan Y, Gao W, Rhee J, Park M et al (2009) Community-based colorectal cancer intervention in underserved Korean Americans. Cancer Epidemiol 33(5):381–386. CrossRefPubMedGoogle Scholar
  80. 80.
    Maxwell AE, Bastani R, Crespi CM, Danao LL, Cayetano RT (2011) Behavioral mediators of colorectal cancer screening in a randomized controlled intervention trial. Prev Med 52(2):167–173. CrossRefPubMedGoogle Scholar
  81. 81.
    Vernon SW, Bartholomew LK, McQueen A, Bettencourt JL, Greisinger A, Coan SP et al (2011) A randomized controlled trial of a tailored interactive computer-delivered intervention to promote colorectal cancer screening: sometimes more is just the same. Ann Behav Med 41(3):284–299CrossRefGoogle Scholar
  82. 82.
    Lipkus IM, Green LG, Marcus A (2003) Manipulating perceptions of colorectal cancer threat: implications for screening intentions and behaviors. J Health Commun 8(3):213–228. CrossRefPubMedGoogle Scholar
  83. 83.
    Moattar M, Roozitalab M, Gholamzadeh S, Firoozi MS, Zare N (2014) Practical application of Health Belief Model to enhance the uptake of colorectal cancer screening. J Community Med Health Educ 4:297. CrossRefGoogle Scholar
  84. 84.
    Vernon SW (1997) Participation in colorectal cancer screening: a review. J Natl Cancer Inst 89(19):1406–1422CrossRefGoogle Scholar

Copyright information

© American Association for Cancer Education 2018

Authors and Affiliations

  1. 1.Nursing Faculty, Oncology Nursing DepartmentUniversity of Health SciencesIstanbulTurkey
  2. 2.Florence Nightingale Nursing Faculty, Public Health Nursing DepartmentIstanbul UniversityIstanbulTurkey

Personalised recommendations